Literature DB >> 12382995

Manipulation of working memory information is impaired in Parkinson's disease and related to working memory capacity.

P Bublak1, U Müller, G Grön, M Reuter, D Y von Cramon.   

Abstract

It has been suggested that in patients with Parkinson's disease (PD), difficulties in the manipulation of information, which result in problems in executive tasks, are related to a reduction of working memory capacity (J. D. E. Gabrieli, J. Singh, G. T. Stebbins, & C. G. Goetz, 1996). The present study selectively varied the manipulation demand irrespective of the maintenance requirement. In a group of 14 PD patients, performance declined overproportionally with the increasing task demand and was significantly correlated with a measure of working memory capacity. These results suggest that the complexity of working memory processing may decisively contribute to the exhaustion of resources in PD patients. Increasing complexity may either affect their manipulation ability directly or impede the management of inhibitory control requirements inherent to the task.

Entities:  

Mesh:

Year:  2002        PMID: 12382995     DOI: 10.1037//0894-4105.16.4.577

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  14 in total

Review 1.  Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.

Authors:  Marc R Bothe; Ingo Uttner; Markus Otto
Journal:  J Neural Transm (Vienna)       Date:  2010-01-30       Impact factor: 3.575

2.  Attention and reach-to-grasp movements in Parkinson's disease.

Authors:  Cathy Lu; Aamir Bharmal; Zelma H Kiss; Oksana Suchowersky; Angela M Haffenden
Journal:  Exp Brain Res       Date:  2010-06-29       Impact factor: 1.972

3.  Screening for cognitive impairment in Parkinson's disease--which marker relates to disease severity?

Authors:  M W Riepe; J Kassubek; F Tracik; G Ebersbach
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

4.  Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson's disease.

Authors:  Joe R Nocera; Catherine Price; Hubert H Fernandez; Shinichi Amano; Srikant Vallabhajosula; Michael S Okun; Nelson Hwynn; Chris J Hass
Journal:  Parkinsonism Relat Disord       Date:  2010-09-09       Impact factor: 4.891

5.  Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans.

Authors:  Kathryn A Ellis; Mitul A Mehta; Keith A Wesnes; Stuart Armstrong; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

6.  Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease.

Authors:  Kolbjorn Bronnick; Murat Emre; Roger Lane; Sibel Tekin; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-07       Impact factor: 10.154

7.  Effects of modafinil on working memory processes in humans.

Authors:  Ulrich Müller; Nikolai Steffenhagen; Ralf Regenthal; Peter Bublak
Journal:  Psychopharmacology (Berl)       Date:  2004-06-24       Impact factor: 4.530

8.  High-level language production in Parkinson's disease: a review.

Authors:  Lori J P Altmann; Michelle S Troche
Journal:  Parkinsons Dis       Date:  2011-08-05

9.  Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.

Authors:  Catherine C Price; Jared Tanner; Peter T Nguyen; Nadine A Schwab; Sandra Mitchell; Elizabeth Slonena; Babette Brumback; Michael S Okun; Thomas H Mareci; Dawn Bowers
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

10.  The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory.

Authors:  Chris M Dodds; Luke Clark; Anja Dove; Ralf Regenthal; Frank Baumann; Ed Bullmore; Trevor W Robbins; Ulrich Müller
Journal:  Psychopharmacology (Berl)       Date:  2009-08-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.